| Name | naltrexone |
|---|---|
| Synonyms |
Dotrex
NeMexin Trexonil Naltrexone //BP 17-(cyclopropylmethyl)-4,5-oxy-3,14-dihydroxymorphinan-6-one (1S,5R,13R,17S)-4-(Cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0.0.0]octadeca-7(18),8,10-trien-14-on Depotrex ReVia Naltrexone (base, anhydrous) en1639 Naltrexone Naltrexone (1.0 mg/mL in Methanol) (5α)-17-(Cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-one C07253 Vivitrex 3,14-Dihydroxy-17-(cyclopropylmethyl)-4,5α-oxymorphinan-6-one Nalorex Depade (5α)-17-(Cyclopropylmethyl)-4,5-oxy-3,14-dihydroxymorphinan-6-one (4R,4aS,7,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one Morphinan-6-one,17-(cyclopropylMethyl)-4,5-oxy-3,14-dihydroxy-, (5a) Naltrexone impurty NaltrexoneBase 4,5α-oxy-3,14β-dihydroxy-17-(cyclopropylmethyl)morphinan-6-one Naltrexone Hydrochloride Impurity 1 Naltrexone trifluoroacetate salt (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0.0.0]octadeca-7(18),8,10-trien-14-one En 1639A Naltrexone (controlled) HCl en1939 Naltrel Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-oxy-3,14-dihydroxy-, (5α) Vivitrol Naltrexone solution Naltrexone (base and/or unspecified salts) Naltrexone Standd celupan Um-792 (5a)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Adamantane Impurity 50 Naltrexone Base & HCL Naltrexone Base Monohydrate 17-(cyclopropylmethyl)-4,5-alpha-oxy-3,14-dihydroxy-morphinan-6-on n-cyclopropylmethyl-14-hydroxydihydromorphinone Antaxone Naltrexone, 1.0 mg/mL trexan 5-oxy-3,14-dihydroxy-17-(cyclopropylmethyl)-(5-alpha)-morphinan-6-on (1S,5R,13R,17S)-4-(cyclopropylméthyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0.0.0]octadéca-7(18),8,10-trién-14-one n-cyclopropylmethylnoroxymorphone |
| Description | Naltrexone is an antagonist of Opioid receptor. Naltrexone inhibits cell proliferation in vivo. Naltrexone reduces tumor growth by interfering with cell signalling and modifying the immune system[1]. |
|---|---|
| Related Catalog | |
| References |
[7]. Naltrexone |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 558.1±50.0 °C at 760 mmHg |
| Melting Point | 168-170ºC |
| Molecular Formula | C20H23NO4 |
| Molecular Weight | 341.40 |
| Flash Point | 291.4±30.1 °C |
| Exact Mass | 341.162720 |
| PSA | 70.00000 |
| LogP | 1.80 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.709 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| Hazard Codes | F,T |
| Risk Phrases | 11-23/24/25-39/23/24/25 |
| Safety Phrases | 16-36/37-45 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
| Precursor 9 | |
|---|---|
| DownStream 6 | |